KURE Holdings — KraneShares MSCI All China Health Care Index ETF
All 46 reported holdings of KraneShares MSCI All China Health Care Index ETF (KURE) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| WuXi AppTec Co., Ltd. | 9.14% | $6.51M |
| BeOne Medicines AG | 8.84% | $6.30M |
| Innovent Biologics, Inc. | 8.80% | $6.27M |
| Wuxi Biologics (cayman) Inc. | 7.51% | $5.35M |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 4.59% | $3.27M |
| Shenzhen Mindray Bio-Medical Electronics Co Ltd | 4.27% | $3.04M |
| Akeso Inc | 3.72% | $2.65M |
| Cspc Pharmaceutical Group Limited | 3.68% | $2.62M |
| Invesco Government & Agency Portfolio | 3.55% | $2.53M |
| Sino Biopharmaceutical Limited | 3.39% | $2.41M |
| Hansoh Pharmaceutical Group Company Limited | 2.85% | $2.03M |
| 3SBio Inc. | 2.49% | $1.77M |
| RemeGen Co Ltd | 2.31% | $1.64M |
| Yunnan Baiyao Group Co., Ltd. | 2.30% | $1.64M |
| Shanghai United Imaging Healthcare Co., Ltd. | 2.27% | $1.62M |
| Aier Eye Hospital Group Co., Ltd. | 2.10% | $1.49M |
| Sichuan Biokin Pharmaceutical Co Ltd | 1.97% | $1.40M |
| Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | 1.85% | $1.32M |
| Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. | 1.81% | $1.29M |
| Sinopharm Group Co. Ltd. | 1.67% | $1.19M |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 1.61% | $1.15M |
| Haisco Pharmaceutical Group Co., Ltd. | 1.53% | $1.09M |
| Huadong Medicine Co., Ltd. | 1.36% | $969.13K |
| WuXi XDC Cayman Inc | 1.35% | $963.92K |
| Shanghai Allist Pharmaceuticals Co Ltd | 1.34% | $954.42K |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 1.30% | $927.30K |
| Legend Biotech Corp | 1.28% | $909.37K |
| Shanghai Pharmaceuticals Holding Co., Ltd. | 1.17% | $832.64K |
| Pharmaron Beijing Co., Ltd. | 1.15% | $817.76K |
| Genscript Biotech Corp | 1.11% | $792.25K |
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | 1.03% | $731.26K |
| XtalPi Holdings Limited | 1.00% | $709.20K |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 0.97% | $693.73K |
| Shenzhen New Industries Biomedical Engineering Co Ltd | 0.90% | $642.87K |
| Beijing Tong Ren Tang Co., Ltd. | 0.86% | $614.48K |
| Shanghai RAAS Blood Products Co., Ltd. | 0.79% | $560.17K |
| Chongqing Zhifei Biological Products Co., Ltd. | 0.76% | $543.29K |
| CSPC Innovation Pharmaceutical Co Ltd | 0.74% | $528.54K |
| Changchun High-Tech Industry (group) Co., Ltd. | 0.74% | $526.95K |
| Imeik Technology Development Co Ltd | 0.72% | $511.79K |
| APT Medical Inc | 0.70% | $497.47K |
| Beijing Wantai Biological Pharmacy Enterprise Co Ltd | 0.67% | $478.54K |
| Hebei Changshan Biochemical Pharmaceutical Co Ltd | 0.56% | $401.95K |
| Hangzhou Tigermed Consulting Co., Ltd | 0.46% | $324.22K |
| Brown Brothers Harriman & Co. | -0.00% | $-93 |
KURE overview: performance, fees, allocation and SEC filings